Literature DB >> 4030699

Patterns of attrition for psychosocial and pharmacologic treatments of depression.

C G Last, M E Thase, M Hersen, A S Bellack, J M Himmelhoch.   

Abstract

Patient characteristics associated with early termination from psychosocial and pharmacologic treatments of depression were delineated. Patients were 125 female primary nonbipolar depressives randomly assigned to 12 weeks of protocol treatment in one of four conditions: social skills training plus placebo; short-term psychotherapy plus placebo; amitriptyline alone; and social skills training plus amitriptyline. Results indicated that premature terminators from pharmacotherapy tended to be mildly depressed and intolerant of medication side effects. In contrast, dropouts from psychosocial treatment were more severely depressed and dissatisfied with the lack of early response which often accompanies interventions of this type. These findings may support the use of short-term psychosocial approaches in lieu of pharmacotherapy in mild nonendogenous depressions. However, antidepressant medication, either alone or in conjunction with psychosocial treatment, should continue to be considered the treatment of choice in more severely depressed melancholic patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030699

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer.

Authors:  Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart
Journal:  Psychooncology       Date:  2011-07-12       Impact factor: 3.894

2.  Predictors of treatment utilization in major depression.

Authors:  Dana M Alonzo; Jill M Harkavy-Friedman; Barbara Stanley; Ainsley Burke; J John Mann; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2011

3.  Impact of organizational change on the intake, referral and treatment of outpatients at a community mental health center.

Authors:  L Salta; W P Buick
Journal:  J Ment Health Adm       Date:  1989

4.  What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Authors:  Diane Warden; A John Rush; Stephen R Wisniewski; Ira M Lesser; Susan G Kornstein; G K Balasubramani; Michael E Thase; Sheldon H Preskorn; Andrew A Nierenberg; Elizabeth A Young; Kathy Shores-Wilson; Madhukar H Trivedi
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

5.  Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray?

Authors:  Eleanor J Murphy; Layla Kassem; Anat Chemerinski; A John Rush; Gonzalo Laje; Francis J McMahon
Journal:  Depress Anxiety       Date:  2013-05-30       Impact factor: 6.505

6.  Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention.

Authors:  Diane Warden; A John Rush; Thomas J Carmody; T Michael Kashner; Melanie M Biggs; M Lynn Crismon; Madhukar H Trivedi
Journal:  J Psychiatr Pract       Date:  2009-03       Impact factor: 1.325

7.  Connection between self-stigma, adherence to treatment, and discontinuation of medication.

Authors:  Dana Kamaradova; Klara Latalova; Jan Prasko; Radim Kubinek; Kristyna Vrbova; Barbora Mainerova; Andrea Cinculova; Marie Ociskova; Michaela Holubova; Jarmila Smoldasova; Anezka Tichackova
Journal:  Patient Prefer Adherence       Date:  2016-07-22       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.